Opdivo Plus Yervoy Reduces the Risk of Colorectal Cancer Disease Progression or Death by 79% Versus Chemotherapy

Posted on by admin
1 min read

Opdivo plus Yervoy shows promise in treating patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours